ChemoCentryx Inc

-1.27 (-1.86%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)4.65B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$7.99 Million
Adjusted EPS-$0.33
See more estimates
10-Day MA$66.38
50-Day MA$62.49
200-Day MA$57.62
See more pivots

ChemoCentryx, Inc. Stock, NASDAQ:CCXI

850 Maude Avenue, Mountain View, California 94043
United States of America
Phone: +1.650.210.2900
Number of Employees: 82


ChemoCentryx, Inc. is a biopharmaceutical company engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in Mountain View, CA.